Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/24/2024 | $9.50 | Overweight | Cantor Fitzgerald |
| 5/26/2023 | $11.00 | Hold → Buy | Kepler |
| 3/25/2022 | $20.00 | Buy → Neutral | Bryan Garnier |
| 10/20/2021 | $28.00 | Overweight | JP Morgan |
| 9/2/2021 | $30.00 | Buy | Stifel |
| 8/9/2021 | $30.00 | Buy | Lake Street |
6-K - MATERIALISE NV (0001091223) (Filer)
6-K - MATERIALISE NV (0001091223) (Filer)
6-K - MATERIALISE NV (0001091223) (Filer)
THIS ANNOUNCEMENT IS NOT DIRECTED AT OR INTENDED TO BE DISTRIBUTED TO PERSONS WHO ARE CITIZEN OR RESIDENT OF OR LOCATED IN SWITZERLAND, CANADA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE THE EXTENSION OF AVAILABILITY OF THIS ANNOUNCEMENT WOULD BREACH ANY APPLICABLE LAW OR REGULATION OF OR WOULD REQUIRE ANY REGISTRATION OR LICENCING WITHIN SUCH JURISDICTION. Regulated information1 Materialise NV ((Euronext &, NASDAQ:MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announced the start of its additional listing of its ordinary shares on Euronext Brussels, to complement the existing Na
Leuven, Belgium, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing software and of sophisticated 3D printing solutions, today announced the results of the votes cast at its Extraordinary Shareholders' Meeting, where all the proposed resolutions were approved. For additional information, please visit: https://investors.materialise.com/ About Materialise NV Materialise NV incorporates more than three decades of 3D printing experience into a range of software solutions and 3D printing services that empower sustainable 3D printing applications. Our open, secure, and flexible end-to-end solutions enable flexible industrial manufac
LEUVEN, Belgium, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing software and sophisticated 3D printing solutions, today announced that it will host an Extraordinary Shareholders' Meeting on Friday, November 14, 2025, at 17:00 CET. The Extraordinary Shareholders' Meeting will take place on November 14, 2025 at 17:00 CET at the registered office of the Company (Technologielaan 15, 3001 Leuven). The deed will be digitally executed by notary Stijn Raes, with office at Kortrijksesteenweg 1147, 9051 Ghent. The Extraordinary Shareholders' Meeting is convened to, among other things, discuss and decide on proposals to proceed with ce
Cantor Fitzgerald initiated coverage of Materialise with a rating of Overweight and set a new price target of $9.50
Kepler upgraded Materialise from Hold to Buy and set a new price target of $11.00
Bryan Garnier downgraded Materialise from Buy to Neutral and set a new price target of $20.00
Fried Vancraen, Co-founder and CEO, to become Chairman of the Board Materialise NV (NASDAQ:MTLS), a global leader in 3D printing software and services, today announced that the company's Board of Directors has appointed Brigitte de Vet-Veithen as Chief Executive Officer. Brigitte de Vet-Veithen will succeed Fried Vancraen, who co-founded Materialise in 1990 and has served as the company's CEO for 33 years. Mr. Vancraen will continue to represent Materialise as the new Chairman of the Board of Directors. The leadership transition will become effective on January 1, 2024, as part of the management changes described below. "We founded Materialise with a mission to create a better and healt
Materialise NV (NASDAQ:MTLS), a global leader in 3D-printed medical devices and software and a pioneer in additive manufacturing software and services, today announced its financial results for the third quarter ended September 30, 2025. Highlights – Third Quarter 2025 Total consolidated revenue increased 2.2% to 66,259 kEUR compared to the second quarter of 2025, but decreased 3.5% compared to the third quarter of 2024. Revenue from our Materialise Medical segment grew 10.3% compared to the corresponding 2024 period. Gross profit as a percentage of revenue for the third quarter of 2025 was 56.8%, in line with the gross margin realized over the first nine months of 2025. Adjusted
Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing software and of sophisticated 3D printing services, today announced that it will release financial results for the third quarter ended September 30, 2025 on Tuesday, October 28, 2025 at 6:30 a.m. ET/11:30 a.m. CET. Senior management will hold a conference call to discuss the third quarter 2025 financial results on Tuesday, October 28, 2025 at 8:30 a.m. ET/1:30 p.m. CET. To access the call by phone, please click the link below at least 15 minutes prior to the scheduled start time and you will be provided with dial-in details. Participants can choose to dial in or receive a call to connect to Materialise's conference
Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing and medical software and of sophisticated 3D printing services, today announced its financial results for the second quarter ended June 30, 2025. Highlights – Second Quarter 2025 Total consolidated revenue decreased 5.8% to 64,831 kEUR compared to the corresponding 2024 period; however at the same time our Materialise Medical segment showed a further 16.7% growth. Gross profit as a percentage of revenue for the second quarter of 2025 increased to 58.3%, compared to 57.0% for the corresponding 2024 period. Adjusted EBIT improved to 3,058 kEUR for the second quarter of 2025 from 646 kEUR for the first quarte
SC 13G/A - MATERIALISE NV (0001091223) (Subject)
SC 13G/A - MATERIALISE NV (0001091223) (Subject)
SC 13G/A - MATERIALISE NV (0001091223) (Subject)